Alector, Inc. ALEC
2.48 USD -0.15 (-5.89%)
Nov 12, 2026, 2:03 PM EST
2.39 Day range 2.66
1.09 52-week range 2.84
- YTD
- +58.65%
- 1 year
- +84.70%
News
zacks.com Are Medical Stocks Lagging Alector (ALEC) This Year? Here is how Alector (ALEC) and CVS Health (CVS) have performed compared to their sector so far this year.
zacks.com Earnings Estimates Rising for Alector (ALEC): Will It Gain? Alector (ALEC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
benzinga.com Alector Q3 EPS $1.11 Beats $(0.23) Estimate, Sales $162.866M Beat $2.678M Estimate Alector (NASDAQ:ALEC) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $(0.23) by 582.61 percent. This is a 426.47 percent increase over losses of $(0.34)…
globenewswire.com Alector Reports Third Quarter 2026 Financial Results and Provides Business Update Advancing a pipeline built entirely on the Alector Brain Carrier (ABC) blood-brain barrier platform, spanning antibody, enzyme, and siRNA programs, with AL137, Alector's lead ABC-enabled anti-amyloid…- benzinga.com Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8 HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8 HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
benzinga.com Morgan Stanley Maintains Underweight on Alector, Raises Price Target to $3 Morgan Stanley analyst Sean Laaman maintains Alector (NASDAQ:ALEC) with a Underweight and raises the price target from $2 to $3.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector…
benzinga.com Alector Teams Up With Genentech On Potential Parkinson’s Treatment Alector, Inc. (NASDAQ:ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced it has entered into an exclusive…
benzinga.com Alpha Buying: Follow the Money From NVIDIA and Merck Wall Street loves a good upgrade, especially when the stock has already doubled and the analyst can explain why everyone should have owned it six months ago. One place I look for ideas is the…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares…
benzinga.com GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company moves to end its collaboration with Alector.
benzinga.com Alector Launches Up To $125M At-The-Market Common Stock Offering Through TD Cowen $125,000,000Common StockWe have entered into a sales agreement with TD Securities (USA) LLC ("TD Cowen") relating to shares of our common stock offered by this prospectus supplement and the…- benzinga.com Alector Q1 EPS $(0.21) Beats $(0.35) Estimate, Sales $1.046M Miss $6.207M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40 percent. This is a 48.78 percent increase over losses of $(0.41) per…
benzinga.com This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Wall Street analysts upgraded CRWD, ALEC, RIVN, SEDG, and DNTH. See what other analysts say about these stocks. Consider buying CRWD.
benzinga.com Alector Q4 Earnings Assessment - benzinga.com Alector Q4 EPS $(0.34) Beats $(0.39) Estimate, Sales $6.237M Beat $2.672M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 13.71 percent. This is a 1600 percent decrease over losses of $(0.02) per…
benzinga.com Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.- benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Lowers Price Target to $5 HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $10 to $5.
benzinga.com Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings 
benzinga.com Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket 
benzinga.com AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Alector Discontinues Open-Label Extension For Latozinemab; Co To Reduce Workforce By About 49% Alector Pipeline OutlookAlector remains focused on advancing a pipeline of programs designed to treat neurodegenerative diseases through mechanisms that remove toxic proteins, replace deficient…
benzinga.com 4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals 4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.
benzinga.com Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com Alector Raises FY2025 Sales Guidance from $5.000M-$15.000M to $13.000M-$18.000M vs $12.114M Est Alector (NASDAQ:ALEC) raises FY2025 sales outlook from $5.000 million-$15.000 million to $13.000 million-$18.000 million vs $12.114 million estimate.
- benzinga.com Alector Q2 EPS $(0.30) Beats $(0.43) Estimate, Sales $7.900M Beat $2.750M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.43) by 29.91 percent. This is a 25 percent increase over losses of $(0.40) per…
- benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Texas Instruments Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday 
benzinga.com Mizuho Upgrades Alector to Outperform, Raises Price Target to $3.5 Mizuho analyst Graig Suvannavejh upgrades Alector (NASDAQ:ALEC) from Neutral to Outperform and raises the price target from $2.5 to $3.5.- benzinga.com Alector Announces Neil Berkley Appointed Interim Chief Financial Officer, Succeeding Marc Grasso, Effective June 20, 2025 -- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D., effective June 20, 2025 --SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Alector,…
- benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $10 HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $7 to $10.
- benzinga.com Alector Q1 EPS $(0.41) Beats $(0.48) Estimate, Sales $3.67M Miss $4.38M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.48) by 14.58 percent. This is a 7.89 percent decrease over losses of $(0.38) per…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Morgan Stanley Assumes Alector at Underweight, Lowers Price Target of $1.5 Morgan Stanley analyst Sean Laaman assumes Alector (NASDAQ:ALEC) with a Underweight rating and lowers Price Target of $1.5.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Alector, Maintains $7 Price Target HC Wainwright & Co. analyst Andrew Fein reiterates Alector (NASDAQ:ALEC) with a Buy and maintains $7 price target.
- benzinga.com Alector Sees FY2025 collaboration revenue to be between $5 million and $15 million Alector (NASDAQ:ALEC) sees FY2025 sales of $5.000 million-$15.000 million vs $62.89 million analyst estimate.
- benzinga.com Earnings Scheduled For February 26, 2025
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session